Beat The Denominator

The most compelling opportunity is Hims & Hers Health (HIMS), which is considered a strong buy following its recent strategic acquisition of Australian telehealth company Eucalyptus. HIMS is viewed as a long-term winner aiming to become a dominant global consumer health platform by disrupting traditional healthcare with its AI-driven model. Similarly, NVIDIA (NVDA) is seen as severely undervalued, as the market has not fully priced in its massive potential in the AI sector. In contrast, legacy businesses like Walgreens (WBA) face an existential threat from these online disruptors and should be avoided. Other major tech stocks like Google (GOOGL) are seen as fairly valued, while Apple (AAPL) is considered a little expensive at current levels.

Consider Tesla (TSLA) as a primary long-term investment for exposure to the emerging humanoid robot industry through its Optimus project. The core thesis is that TSLA is a unique technology company whose future value in robotics and other ventures is currently underestimated by the market. For a higher-risk, value-oriented approach to the same theme, look at Chinese EV maker XPeng (XPEV). Its extremely low valuation, with a price-to-sales ratio around 0.17, is seen as compensation for the geopolitical risks of investing in China. Owning XPEV offers a speculative call option on its own humanoid robot, the 'Iron Bot,' with its core EV business providing a potential valuation floor.

Consider allocating to Bitcoin (BTC) as a primary long-term store of value, viewing its digital scarcity as superior to physical assets like Gold (GLD). For core equity exposure, favor the tech-focused Invesco QQQ Trust (QQQ) over the S&P 500 for its rules-based, innovation-oriented structure. Income-seeking investors could explore MicroStrategy's "Stretch" debt instrument, which offers a high, tax-deferred yield heavily collateralized by Bitcoin. In contrast, traditional safe-haven assets like US Treasury bonds (TLT) are now considered high-risk and should be avoided due to political and fiscal instability.

Consider MicroStrategy (MSTR) as a long-term, leveraged investment in Bitcoin, as the company aggressively uses its stock to acquire more of the cryptocurrency. The company's strategy of selling new MSTR shares to buy Bitcoin is viewed as beneficial for shareholders because the stock trades at a premium to its underlying crypto assets. This immense buying pressure from institutions like MSTR creates a strong long-term bullish case for Bitcoin (BTC) due to a potential supply and demand imbalance. Current market fear and price weakness in Bitcoin should be viewed as a strategic buying opportunity for long-term accumulators. For investors with a long-term horizon into the 2030s, beaten-down innovative growth stocks like Tesla (TSLA) and AMD (AMD) may also present a significant buying opportunity.

The long-term outlook for Bitcoin (BTC) is considered bullish, as fears of a quantum computing threat are overblown and not a risk for modern wallets. Investors holding BTC in very old paper wallets from before 2015 should move their funds to a modern wallet to ensure security. A future quantum-proof upgrade for Bitcoin is viewed as a positive event that could increase scarcity and value. Conversely, the quantum computing sector is considered too immature for investment, with companies like IONQ (IONQ) still in the early "lab stage." The primary investment opportunity is to remain confident in Bitcoin, as the technology for a quantum attack is likely decades away.

Consider buying Oddity Tech (ODD), which is viewed as a significantly undervalued AI-driven beauty company whose stock has fallen over 50% without negative news. The company acts as a "brand machine," successfully launching billion-dollar brands like Il Makiage and Spoiled Child by using AI to offer personalized products directly to consumers. This technology gives ODD a powerful competitive advantage over slower, traditional competitors like L'Oreal and Estee Lauder. Financially, the company is strong, consistently beating its growth and profitability targets. The recent stock decline presents a potential buying opportunity in a disruptive company that the market seems to be overlooking.

Consider buying Bitcoin (BTC) as the Fear & Greed Index rebounds from extreme lows, signaling a potential market bottom and improving sentiment. For stock market exposure, MicroStrategy (MSTR) offers a leveraged play on Bitcoin through its consistent accumulation strategy. Be cautious this week, as Nvidia's (NVDA) earnings report on Wednesday is a critical event that will likely cause significant market volatility. The market's reaction to NVDA will be a key indicator of near-term sentiment for tech stocks. Longer-term, potential Fed rate cuts later this year could provide a major tailwind for assets like Bitcoin.

A contrarian opportunity exists for investors bullish on Solana (SOL) to gain exposure at a significant discount through specific publicly traded stocks. The highest conviction pick is Forward Industries (FWDI), which holds SOL on its balance sheet and trades at a discount to its net asset value. By purchasing FWDI, investors can effectively acquire Solana at an approximate 34% discount to its current market price. Furthermore, FWDI generates an enhanced yield on its crypto holdings and its management is actively buying back shares. This is a high-risk investment suitable for a small allocation, as its value is directly tied to the volatile price of SOL.

Duolingo (DUOL) is considered a "dirt cheap" buying opportunity as the market overestimates the threat of AI to its language-learning business. The company's fundamentals remain strong, with daily active users and paid subscribers growing rapidly despite the stock's decline. A key upcoming catalyst is the Q4 earnings report, which could present a prime buying opportunity. Consider initiating a position in DUOL if the company reports strong results but the stock price reacts negatively. For a less volatile opportunity, ServiceNow (NOW) has also entered an attractive valuation zone for investors seeking stable, large-cap growth.

For amplified exposure to Bitcoin, consider MicroStrategy (MSTR), which is outperforming direct Bitcoin holdings and is viewed as a high-conviction leveraged play. The outlook for Bitcoin itself is constructive after bouncing from the $60,000 level, which may have been a short-term bottom. A favorable macroeconomic environment, with rising odds of a June Federal Reserve rate cut, provides a strong tailwind for crypto assets. The rapid price recovery in the YieldMax MSTR Option Income Strategy ETF (MSTY) after its monthly dividend payout signals strong underlying demand for MSTR-related assets. This indicates that post-dividend dips in MSTY may present recurring buying opportunities for investors.

A strong bullish case is presented for Hims & Hers Health (HIMS), with the recent stock decline viewed as a significant buying opportunity ahead of a potential turnaround. The upcoming earnings call on February 23rd is a critical short-term catalyst that could reverse the stock's negative trend. Investors should monitor for updates on the company's $250 million share buyback program and early results from new growth areas like Testosterone and Menopause treatments. The core thesis is that the market is overly focused on GLP-1 risks while ignoring the strong core business and long-term AI potential. For those interested in similar beaten-down growth stocks, Oddity Tech (ODD) is highlighted as a quality company with a comparable business model.

MicroStrategy (MSTR) is showing significant relative strength against Bitcoin, signaling a positive sentiment shift and a potential bottom for the stock. This strength is fueled by the company's aggressive Bitcoin acquisition via its STRC convertible notes, which are experiencing record-breaking institutional demand. While sentiment on Bitcoin (BTC) is at "extreme fear" levels, this underlying buying pressure presents a powerful long-term bullish catalyst. Investors could consider MSTR as a primary vehicle for Bitcoin exposure, as it is currently demonstrating more favorable momentum than the underlying asset. Given the divergence, consider favoring the equity over the asset itself in the near term.

The current market is favoring "vibe" stocks over fundamentals, creating an opportunity in undervalued technology companies like Nebius (no ticker). Nebius is a high-conviction AI infrastructure play whose stock is disconnected from its projected 600% revenue growth by year-end 2026. The company's growth is validated by major contracts with Meta (META) and a future $19 billion deal with Microsoft (MSFT) expected to ramp up by 2027. Furthermore, Nebius holds significant "hidden value" through its stakes in private companies like data analytics firm ClickHouse. Investors should watch for a potential sale of these venture capital holdings, which could serve as a major catalyst for the stock.

SoFi (SOFI) is presented as a significantly undervalued opportunity, with a belief that the stock should be trading at $30 based on its strong revenue growth. Consider software company Zeta Global (ZETA), described as one of the cheapest value plays in its sector while trading under $15. The recent drop in Pagaya (PGY) is viewed as a market-driven overreaction, making the stock "dirt cheap" for value investors. The 20% sell-off in Palantir (PLTR) is seen as an unjustified entry point for a company with outstanding execution. The core insight is to favor these innovative growth stocks over "old world" companies whose recent rallies lack fundamental support.

With market sentiment in "extreme fear," consider accumulating Bitcoin while the price is near $66,000. For stock exposure, the recent weakness in MicroStrategy (MSTR) common stock presents a potential buying opportunity, as the company may be acquiring more Bitcoin. It is recommended to focus on MSTR common stock over its preferred shares for its greater upside potential. Active traders might watch the preferred stock STRC for a high-risk trade, aiming to buy near $94 and sell at its $100 target. The core insight is that a recovery in risk assets is the key catalyst, suggesting investors should look past the current negative sentiment.

Innovative small-cap growth stocks are seen as significantly undervalued due to broad market sell-offs, creating a potential buying opportunity for long-term investors. SoFi (SOFI) is highlighted as a premier fintech company with strong fundamentals, viewed as a long-term winner poised to become a top 10 bank. Similarly, Robinhood (HOOD) is considered a clear buying opportunity after a recent 35% drop, with its new credit card acting as a major growth catalyst. In the beauty sector, Oddity Tech (ODD) is presented as "dirt cheap" after a 50% decline, offering strong growth without the legal risks facing competitors. These companies are being punished by market mechanics rather than poor performance, making them attractive at current prices.

The recent price drop in Hims & Hers Health (HIMS) is viewed as a significant buying opportunity, as the market has overreacted to lawsuit news. HIMS can continue selling its GLP-1 products during the multi-year legal process, yet the stock price near $17 seems to incorrectly factor in zero future growth from this category. On a growth-adjusted basis, the stock is considered the cheapest it has ever been. Separately, Oscar Health (OSCR) appears significantly undervalued following its strong earnings report and robust forward guidance. The health insurer is trading at a mere 0.06 times forward revenue despite guiding for exceptional 61% year-over-year growth.

Consider MicroStrategy (MSTR) as a leveraged investment in Bitcoin (BTC), as its stock is designed to be significantly more volatile. Expect MSTR's price to move approximately 1.5 times that of Bitcoin, amplifying both gains and losses. This makes MSTR a higher-risk, higher-potential-reward way to gain exposure to the digital asset. However, be aware that prominent figures believe the market is currently in a bear market, suggesting a period of caution. Investors should understand this amplified risk profile, especially during market downturns.

Regulatory pressure from the FDA and CMS presents a significant headwind for Novo Nordisk (NVO), making it a less attractive investment for growth. A recent FDA warning letter regarding Wegovy marketing highlights the immediate risk and potential for limited top-line growth. In contrast, Hims & Hers Health (HIMS) is positioned as a more investable company due to its telehealth model that currently avoids direct regulatory scrutiny. HIMS's focus on general wellness and longevity allows for more flexible marketing compared to traditional pharmaceutical companies. Investors should consider the significant advantage telehealth platforms have over heavily regulated "Big Pharma" stocks.

The recent price drop in Hims & Hers Health (HIMS) is presented as a significant buying opportunity for long-term investors, as the stock is considered to be at its cheapest valuation level ever. The core thesis is that HIMS is a powerful marketing company disrupting healthcare, with its current legal issues being a temporary overreaction. For a different approach to the weight loss market, consider Eli Lilly (LLY) as the expected future leader. LLY is predicted to dominate the market by year-end 2026 due to its superior next-generation drug pipeline. While HIMS is a high-risk play on its current valuation, LLY is a bet on long-term market leadership.